Gf Fund Management Co. Ltd. Arcutis Biotherapeutics, Inc. Transaction History
Gf Fund Management Co. Ltd.
- $4.26 Trillion
- Q1 2025
A detailed history of Gf Fund Management Co. Ltd. transactions in Arcutis Biotherapeutics, Inc. stock. As of the latest transaction made, Gf Fund Management Co. Ltd. holds 2,996 shares of ARQT stock, worth $43,142. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,996
Previous 2,458
21.89%
Holding current value
$43,142
Previous $34.2 Million
36.85%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding ARQT
# of Institutions
252Shares Held
126MCall Options Held
605KPut Options Held
170K-
Suvretta Capital Management, LLC New York, NY11.4MShares$164 Million7.82% of portfolio
-
Jennison Associates LLC11.4MShares$164 Million0.13% of portfolio
-
Rubric Capital Management LP New York, NY11MShares$158 Million4.91% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA8.79MShares$127 Million8.65% of portfolio
-
Black Rock Inc. New York, NY8.62MShares$124 Million0.0% of portfolio
About Arcutis Biotherapeutics, Inc.
- Ticker ARQT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,187,500
- Market Cap $867M
- Description
- Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. Its lead product candidate is ARQ-151, a topical roflumilast cream that has completed Phase III clinical trials for the treatment of plaque psoriasis and atopic dermatitis. The company is also developing A...